RecruitingNCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Sponsor

Osaka Metropolitan University

Enrollment

2,000 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Diabetes Mellitus Insulin Sensitivity/Resistance Obesity Metabolic Syndrome Hypertension Atherosclerosis Type 2 Diabetes Mellitus (T2DM)Type 2 Diabetes Chronic Kidney Disease(CKD)Hyperglycemia Hyperlipidemia Dyslipidemia Hyperuricemia or Gout Hyperuricemia, Gout Obesity/Epidemiology Obesity, Abdominal Central Obesity Visceral Fat Hepatic Steatosis

Summary

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.

Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This is a community health study in Osaka, Japan, examining factors that contribute to heart disease and metabolic conditions (like diabetes and obesity) in the general population. Part 2 is collecting follow-up data from participants already enrolled in the ongoing Ohtori cohort study. **You may be eligible if...** - You were previously enrolled in the Osaka Cardiometabolic Epidemiological Study (Ohtori cohort) and are returning for follow-up assessments **You may NOT be eligible if...** - You are a woman who may be pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.